Viridian Therapeutics Ownership | Who Owns Viridian Therapeutics?
Viridian Therapeutics Ownership Summary
Viridian Therapeutics is owned by 54.74% institutional investors, 0.14% insiders, and 45.13% retail investors. Fmr is the largest institutional shareholder, holding 15.01% of VRDN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.75% of its assets in Viridian Therapeutics shares.
VRDN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Viridian Therapeutics | 54.74% | 0.14% | 45.13% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 12.25M | 15.01% | $264.34M |
| Blackrock funding, inc. /de | 6.43M | 7.86% | $200.16M |
| Blackrock | 4.77M | 7.81% | $62.10M |
| Vanguard group | 5.61M | 6.86% | $174.65M |
| Deep track capital, lp | 5.38M | 6.59% | $116.11M |
| Kynam capital management, lp | 4.43M | 5.43% | $95.55M |
| Vr adviser | 3.88M | 4.76% | $83.79M |
| Fairmount funds management | 3.46M | 4.24% | $74.66M |
| Commodore capital lp | 3.20M | 3.92% | $69.06M |
| Tang capital management | 2.84M | 3.48% | $61.35M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Propel bio management | 282.53K | 7.51% | $8.79M |
| Kynam capital management, lp | 4.43M | 7.11% | $95.55M |
| Fairmount funds management | 3.46M | 6.72% | $74.66M |
| 5am venture management | 736.60K | 5.82% | $15.90M |
| Rosalind advisors | 450.00K | 4.92% | $14.00M |
| Vr adviser | 3.88M | 4.72% | $83.79M |
| Kopp family office | 173.17K | 3.44% | $5.39M |
| Commodore capital lp | 3.20M | 3.37% | $69.06M |
| Novo | 2.38M | 3.31% | $51.36M |
| Deep track capital, lp | 5.38M | 3.24% | $116.11M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 1.74M | 0.00% | 1.55M |
| Vanguard group | 5.61M | 0.00% | 1.28M |
| Jennison associates | 1.15M | 0.02% | 1.15M |
| Perceptive advisors | 1.46M | 0.91% | 1.01M |
| Blackrock funding, inc. /de | 6.43M | 0.00% | 1.00M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Maverick capital | - | - | -2.21M |
| Ecor1 capital | - | - | -1.96M |
| Commodore capital lp | 3.20M | 3.37% | -1.68M |
| Polar capital | - | - | -889.20K |
| Great point partners | - | - | -750.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Jennison associates | 1.15M | 0.02% | 1.15M | $35.91M |
| Skandinaviska enskilda banken ab (publ) | 286.32K | 0.04% | 286.32K | $8.91M |
| Privium fund management b.v. | 173.52K | 0.99% | 173.52K | $5.40M |
| Centerbook partners lp | 136.72K | 0.21% | 136.72K | $4.25M |
| Norges bank | 122.79K | 0.00% | 122.79K | $3.82M |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -4.00 |
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Principal securities | -9.00 |
| Creative financial designs inc /adv | -10.00 |
| Montag a & associates | -12.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 145 | -17.14% | 44,766,785 | -51.97% | 54 | 0.42% | 101 | 46.38% | 28 | -57.58% |
| Sep 30, 2025 | 172 | -1.15% | 92,157,310 | -2.54% | 112 | 0.84% | 68 | -21.84% | 65 | 1.56% |
| Jun 30, 2025 | 174 | -1.69% | 94,556,349 | 8.58% | 115 | 1.01% | 87 | -6.45% | 64 | 16.36% |
| Mar 31, 2025 | 179 | -6.28% | 91,344,327 | 0.33% | 112 | 0.60% | 92 | -24.59% | 55 | 34.15% |
| Dec 31, 2024 | 186 | 6.29% | 85,180,374 | -2.05% | 128 | 0.75% | 118 | 7.27% | 40 | -4.76% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.80M | 2.75% | 9.86K |
| Vanguard US Total Market Shares ETF | 2.24M | 2.75% | 324.50K |
| Fidelity Select Health Care | 2.80M | 2.75% | -40.00K |
| iShares Russell 2000 ETF | 1.92M | 1.89% | 1.36M |
| Fidelity Advisor Biotechnology I | 1.78M | 1.75% | - |
| State Street® SPDR® S&P® Biotech ETF | 1.72M | 1.69% | -9.20K |
| Fidelity Advisor Health Care I | 1.50M | 1.47% | -20.00K |
| Fidelity Small Cap Growth | 1.27M | 1.25% | 14.00K |
| SPDR® S&P Biotech ETF | 931.02K | 1.14% | 2.08K |
| AB Small Cap Growth A | 869.99K | 1.07% | -12.97K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 31, 2025 | Tousignant Jennifer | Chief Legal Officer | Sell | $70.80K |
| Oct 23, 2025 | Fairmount Funds Management LLC | Buy | $10.00M | |
| Sep 27, 2024 | Beetham Thomas W. | Chief Operating Officer | Buy | $117.05K |
| Sep 27, 2024 | Mahoney Stephen F. | President and CEO | Buy | $499.26K |
| Sep 13, 2024 | Fairmount Funds Management LLC | Buy | $30.00M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | 1 | 1 |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
VRDN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools